In the BioHarmony Drug Report Database

"Preview" Icon

Ozenoxacin

Xepi (ozenoxacin) is a small molecule pharmaceutical. Ozenoxacin was first approved as Xepi on 2017-12-11. It is used to treat impetigo in the USA. Xepi’s patents are valid until 2032-01-29 (FDA).

 

Trade Name

 

Xepi
 

Common Name

 

ozenoxacin
 

ChEMBL ID

 

CHEMBL3990047
 

Indication

 

impetigo
 

Drug Class

 

Antibacterials (quinolone derivatives)

Image (chem structure or protein)

Ozenoxacin structure rendering